HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Martek Reaches Beyond Infant Formula To Grab Perinatal, Food Markets

This article was originally published in The Tan Sheet

Executive Summary

Martek Biosciences is supplying DHA for Mission Pharmacal's upcoming Rx perinatal dietary supplement Citracal + DHA, the firm announced during a presentation to investors

You may also be interested in...



Martek DHA Gets Consumer-Friendly For Upcoming Functional Food Launches

A DHA-enriched Kellogg product may be the first functional food to launch with Martek's new life'sDHA brand name and logo on its label, according to a Sept. 6 analysts call

Martek partners with Hain

Martek will serve as the exclusive DHA and ARA supplier for all Hain Celestial infant formula products in the U.S., under a license and supply agreement announced Aug. 8. The companies also said they are discussing the potential expansion of their relationship into other food and beverage products. Martek's vegetarian source of omega-3 and omega-6 fatty acids will be included in Hain Celestial's infant formula Earth's Best at levels shown through research to optimize brain and eye development. Martek's blend of DHA and ARA is the only source of these fatty acid nutrients used in U.S. infant formula 1("The Tan Sheet" June 19, 2006, In Brief and 2"The Tan Sheet" Jan. 16, 2006, p. 12). Hain Celestial manufactures products under brands such as Rice Dream and WestSoy...

High Omega-3 Intake Protective Against Age-Related Macular Degeneration

A higher intake of omega-3 fatty acids (median of .35 g/day) could have prevented an estimated 22% of the cases of age-related macular degeneration (AMD) in a recent study, according to the study's authors

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS126027

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel